Alan Louis Urban's most recent trade in GT Biopharma Inc was a trade of 23,335 Option to purchase Common Stock done . Disclosure was reported to the exchange on Oct. 17, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GT Biopharma Inc | Alan Louis Urban | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2024 | 23,335 | 23,335 | - | - | Option to purchase Common Stock | |
| GT Biopharma Inc | Alan Louis Urban | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.55 per share. | 20 Sep 2021 | 5,710 | 340,602 | - | 2.6 | 14,561 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 22,303 | 346,312 | - | 0 | Common Stock | |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 18 Jun 2021 | 5,000 | 326,509 | - | 2.4 | 12,150 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.50 per share. | 18 Jun 2021 | 2,500 | 324,009 | - | 2.5 | 6,250 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 14 Jun 2021 | 5,000 | 331,509 | - | 2.5 | 12,250 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Sale of securities on an exchange or to another person at price $ 2.40 per share. | 07 Jun 2021 | 10,000 | 336,509 | - | 2.4 | 24,000 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 07 Jun 2021 | 1,800 | 346,509 | - | 1.3 | 2,250 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 1,800 | 0 | - | - | Common Stock Warrants (right to buy) | |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 7,419 | 344,709 | - | 0 | Common Stock | |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.15 per share. | 20 Mar 2021 | 3,250 | 337,290 | - | 2.2 | 6,988 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 4,618 | 340,540 | - | 0 | Common Stock | |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.21 per share. | 20 Dec 2020 | 24,167 | 335,922 | - | 2.2 | 53,409 | Common Stock |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2020 | 5,399 | 360,089 | - | 0 | Common Stock | |
| Research Solutions Inc | Alan Louis Urban | CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.29 per share. | 20 Sep 2020 | 12,500 | 354,690 | - | 2.3 | 28,625 | Common Stock |